Korea University Anam Hospital

SEOUL, South Korea, Oct. 21, 2024 /PRNewswire/ -- Doctorpresso's study to detect depression from user-generated diary text data was published in the September 2024 issue of the Journal of Medical Internet Research (JMIR) in recognition of its excellence. JMIR noted the "new approach of Doctorpresso's digital mental health screening." Continue Reading DoctorPresso Mind Diary According to Doctorpresso (CEO Whanbo Jung), a new AI technology has been developed to detect depression by utilizing user-generated diary text data. The study suggests an innovative approach for the early diagnosis and treatment of depression, which is increasing worldwide. Depression is a serious social problem around the world, causing a decrease in job productivity and a high burden of disability. However, existing depression screening tools have limitations in objectivity and accuracy, so new methods were needed to compensate for this. The study developed an AI algorithm to detect depression based on user's diary data obtained through Doctorpresso's own diary application and verified its usefulness. According to the study, GPT 3.5 and GPT 4.0, AI-based large language models (LLMs), can effectively detect the risk of depression by analyzing the user's diary text. Specifically, for AI developed using LLM models, text-based depression detection accuracy of 90.2 percent and specificity of 95.5 percent were achieved. Through this, Doctorpresso has secured technology to screen for depression early based on user-generated diary data. "Diary writing is known as a therapeutic tool that promotes emotional expression and self-reflection, and this study confirmed that such textual data can be very useful for early diagnosis of depression," said Dr. Daun Shin (Chief Medical Officer of Doctorpresso, Department of Psychiatry at Korea University Anam Hospital), who led the study. "The importance of research on qualitative digital expression as well as quantitative indicators will increase." Doctorpresso's technology using this study is expected to contribute greatly to early detection of depression and helping better treat and prevent it. SOURCE DoctorPresso WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In GET STARTED

A government-funded initiative to seamlessly connect hospitals, government, insurers, and medical device manufacturers in the whole care process based on digital therapeutics and big data has commenced at Yonsei University Health System. Yonsei's Severance Hospital recently started prescribing the insomnia DTx Somzz through the integrated platform called Connect-DTx. HOW IT WORKS Connect-DTx can collect health data from the patient user in near real-time once prescribed for DTx. Doctors can use this data to adjust and personalise their patient's treatment. When used by admitted patients, Connect-DTx can link to the hospital EMR to also collect their data. Beyond the care team, the platform also connects with government regulators and insurers. The National Health Insurance Corporation and the Ministry of Food and Drug Safety, for example, can easily inquire into the progress of DTx-based treatments and process insurance claims and reviews through Connect-DTx. Additionally, DTx manufacturers can track which health institutions are using their products without reaching out to them individually to confirm. Seoul St. Mary's Hospital, Boramae Hospital, Wonju Severance Christian Hospital, Korea University Anam Hospital, and Seoul National University Bundang Hospital are all in the process of onboarding and implementing Connect-DTx. More DTx devices for other conditions, such as dementia, Parkinson's disease, and smoking cessation, will be introduced soon. WHY IT MATTERS In 2022, YUHS received 7.8 billion won ($5.8 million) from the South Korean Ministry of Trade, Industry and Energy to develop Connect-DTx. The aim is to provide convenient and safe access to patient health information collected in near real-time from DTx devices and hospital EMRs. This allows doctors to tap into data and be better informed before making personalised treatments for their patients. It also enables the government and insurers to easily review and process insurance claims. THE LARGER TREND Somzz, an insomnia DTx developed by Aimmed, is the first of its kind to be approved in South Korea. It delivers cognitive behavioural therapy (CBT) that is said to help increase sleep in patients. Just four months after Aimmed's clearance in January 2023, Welt received the second approval for its insomnia DTx called WELT-I. These market approvals come as the number of South Koreans dealing with insomnia increased almost twice over the past decade. Today, at least 15% of the population is dealing with chronic insomnia. CBT has become a first-line treatment for this condition, and incorporating it in mobile applications is helping bridge access to this treatment, which is said to be more effective than popping regular sleeping pills. ON THE RECORD "The development of the Connect-DTx platform has made it possible for industry stakeholders such as medical institutions, government ministries and medical device companies to conveniently and safely utilise medical data as well as provide personalised treatment to patients," YUHS Digital Health Department head Joon-Seok Lim said about Connect-DTx. "We expect this to be a catalyst for an era of cutting-edge medical care based on big data that systematically analyses patients’ daily life algorithms and treatment patterns that were once difficult to ascertain," he added.

HIMSS and the Korean Hospital Association inked a memorandum of understanding yesterday to drive digital transformation in South Korea's healthcare sector. The partnership will see KHA member hospitals leveraging the HIMSS Digital Health Indicator and subsequently the HIMSS Maturity Model assessments with the goal of advancing their digital healthcare capabilities. Under the agreement, five KHA member hospitals will be undergoing the DHI assessment this year. Other areas the organisations will collaborate on include cross-promoting conferences and events such as the HIMSS APAC Conference and the K-Hospital Fair organised by KHA, and recruiting South Korea’s healthcare community to participate in the HIMSS Certified Professional in Digital Health Transformation Strategy (CPDHTS) programme. The KHA was founded in 1959 with the aim of contributing to the improvement of healthcare and the prosperity of humanity. The organisation conducts research on domestic medical policies and hospital system operations, provides education for hospitals and hospital workers, and works to improve the quality of hospitals and medical treatment. THE LARGER TREND A number of digital health milestones have been observed in South Korea recently. Samsung Medical Center achieved a top score for the HIMSS 2022 DHI ranking , alongside Stage 7 validations for the HIMSS Electronic Medical Record Adoption Model (EMRAM) and Digital Imaging Adoption Model (DIAM). Korea University Anam Hospital was also recognised for its commendable DHI score last year. At a policy level, the South Korean government has made a call to institutionalise telehealth and revise the rules around the application and approval of innovative medical devices to allow more AI-powered and digital technology devices to be immediately used in clinical settings. ON THE RECORD "Today’s partnership signals our intent to collaborate with one of the most important stakeholders in the South Korean healthcare community to advance to the next level. HIMSS is committed to support KHA members in their digital transformation to rank among the best healthcare organisations in the world," shared Simon Lin, HIMSS VP and Managing Director for Asia-Pacific. "This agreement gives me confidence. Confidence that we can prepare for the future of digital transformation, by exploring various areas of medical information in cooperation with HIMSS. I believe that this close-knit collaboration will not only strengthen the global health capabilities of the Korean medical sector but also help shape the vision for global medical IT," said KHA President Dr Dong-Sup Yoon.